1. Home /
  2. Drug Approvals

Drug Approvals

Invest in AbbVie? I've Made My Decision

The dividend in ABBV is key to making any investment decision regarding the stock.

Is Moderna's Bumpy Ride Lower Over for Now?

The stock is trading higher Monday on full approval for its Covid vaccine.

BioMarin Pharmaceutical Is Ready to Start a Fresh Advance

Here's where aggressive traders could go long BMRN.

I Don't Love Biogen, But Here's How to Trade It

I'm not saying get married to the stock, I'm saying that the idea could be a trade based on two possible catalysts.

Pfizer Is a Low-Beat, Dividend Stock: Here's What Patient Investors Can Do

Pfizer attributed the quarter's sales of Comirnaty, the firm's Covid-19 Messenger RNA vaccine, for the size of the top and bottom line beats.

2 Promising Small Biotechs in a Year That Has Been Tough on Most Little Guys

There are reasons to believe the shares of Dynavax Technologies and Eyenovia Inc. could do well in the months ahead.

What a Week, China's Troubles, Hypersonic Weapons, Earnings, FDA Drug Approvals

The lack of urgency at the FDA, as it is in the defense space, is alarming.

Glimmers of Hope in the Biotech Realm as M&A Activity Picks Up

A recent trio of acquisition deals indicates the doldrums in the sector may be over.

Merck Continues to Reward Buyers

Investors are using the available weakness to buy the stock.